Ganoderma lucidum, Ling Zhi -Scientific Studies In Vitro

STUDIES:

http://www.asiancancerherb.info/Chi%20Ling%20Zhi.htm

IN VITRO:

1. Tang W, et al., A randomized, double-blind and placebo-controlled study of a Ganoderma lucidum polysaccharide extract in neurasthenia. J Med Food. 2005 Spring; 8(1):53-8.
2. Kimura Y. New anticancer agents: in vitro and in vivo evaluation of the antitumor and antimetastatic actions of various compounds isolated from medicinal plants. In Vivo. 2005 Jan-Feb; 19(1):37-60.
3. Stanley G, et al., Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells. Biochem Biophys Res Commun. 2005 Apr 29;330(1):46-52.
4. Gu YH, et al., Selective induction of apoptosis in murine skin carcinoma cells (CH72) by an ethanol extract of Lentinula edodes.Cancer Lett. 2005 Mar 18; 220(1):21-8.
5. Boon H, et al., Botanical medicine and cancer: a review of the safety and efficacy. Expert Opin Pharmacother. 2004 Dec; 5(12):2485-501.
6. Zhang W, et al., [Progress in research on Ganoderma lucidium spore]. Zhong Xi Yi Jie He Xue Bao. 2004 Nov; 2(6):463-5. Review. Chinese.
7. Lu QY, et al., Ganoderma lucidum extracts inhibit growth and induce actin polymerization in bladder cancer cells in vitro. Cancer Lett. 2004 Dec 8; 216(1):9-20.
8. Jiang J, et al., Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt/NF-kappaB signaling. Nutr Cancer. 2004; 49(2):209-16.
9. Sun J, et al., Novel antioxidant peptides from fermented mushroom Ganoderma lucidum.J Agric Food Chem. 2004 Oct 20; 52(21):6646-52.
10. Hong KJ, et al., Effects of Ganoderma lucidum on apoptotic and anti-inflammatory function in HT-29 human colonic carcinoma cells. Phytother Res. 2004 Sep; 18(9):768-70.
11. Lu QY, et al., Ganoderma lucidum spore extract inhibits endothelial and breast cancer cells in vitro. Oncol Rep. 2004 Sep; 12(3):659-62.
12. Hsiao WL, et al., Medicinal mushroom extracts inhibit ras-induced cell transformation and the inhibitory effect requires the presence of normal cells. Carcinogenesis. 2004 Jul; 25(7):1177-83.
13. Cao QZ, et al., Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide. Acta Pharmacol Sin. 2004 Jun; 25(6):833-8.
14. Tomasi S, et al., Cytotoxic activity of methanol extracts from Basidiomycete mushrooms on murine cancer cell lines. Pharmazie. 2004 Apr; 59(4):290-3.
15. Jiang J, et al., Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3. Int J Oncol. 2004 May; 24(5):1093-9.
16. deVere White RW, et al., Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer. Urology. 2004 Feb; 63(2):259-63.
17. Wachtel-Galor S, et al., Ganoderma lucidum ("Lingzhi"), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study. Br J Nutr. 2004 Feb; 91(2):263-9.
18. Iwatsuki K, et al., Lucidenic acids P and Q, methyl lucidenate P, and other triterpenoids from the fungus Ganoderma lucidum and their inhibitory effects on Epstein-Barr virus activation. J Nat Prod. 2003 Dec; 66(12):1582-5.
19. Sliva D, et al., Biologic activity of spores and dried powder from Ganoderma lucidum for the inhibition of highly invasive human breast and prostate cancer cells. J Altern Complement Med. 2003 Aug; 9(4):491-7.
20. Berovic M, et al., Submerged cultivation of Ganoderma lucidum biomass and immunostimulatory effects of fungal polysaccharides. J Biotechnol. 2003 Jun 12; 103(1):77-86.
21. Ning J, et al., Synthesis of beta-(1-->6)-branched beta-(1-->3) glucohexaose and its analogues containing an alpha-(1-->3) linked bond with antitumor activity. Bioorg Med Chem. 2003 May 15; 11(10):2193-203.
22. Lin SB, et al., Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest.Life Sci. 2003 Apr 11; 72(21):2381-90.
23. Miura T, et a., Isoflavone aglycon produced by culture of soybean extracts with basidiomycetes and its anti-angiogenic activity. Biosci Biotechnol Biochem. 2002 Dec; 66(12):2626-31.
24. Li P, et al., [Isolation, purification and bioactivities of exopoly saccharides from fermented broth of Ganoderma lucidum]. Wei Sheng Wu Xue Bao. 2000 Apr; 40(2):217-20. Chinese.
25. Kimura Y, et al., Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance. Anticancer Res. 2002 Nov-Dec; 22(6A):3309-18.
26. Sliva D, et al., Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochem Biophys Res Commun. 2002 Nov 8; 298(4):603-12.
27. Hu H, et al., Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Int J Cancer. 2002 Nov 20; 102(3):250-3.
28. Ghafar MA, et al., Regression of prostate cancer following administration of Genistein Combined Polysaccharide (GCP), a nutritional supplement: a case report. J Altern Complement Med. 2002 Aug; 8(4):493-7.
29. Liu X, et al., Antitumor activity of the sporoderm-broken germinating spores of Ganoderma lucidum. Cancer Lett. 2002 Aug 28;182(2):155-61.
30. Hsieh TC, et al., Mechanism of action of herbal supplement PC-SPES: elucidation of effects of individual herbs of PC-SPES on proliferation and prostate specific gene expression in androgen-dependent LNCaP cells. Int J Oncol. 2002 Mar; 20(3):583-8.
31. Lee JM, et al., Inhibition of lipid peroxidation and oxidative DNA damage by Ganoderma lucidum. Phytother Res. 2001 May; 15(3):245-9.